JPH0779711B2 - Method for producing indoline-2-carboxylic acid by optical resolution - Google Patents
Method for producing indoline-2-carboxylic acid by optical resolutionInfo
- Publication number
- JPH0779711B2 JPH0779711B2 JP13953493A JP13953493A JPH0779711B2 JP H0779711 B2 JPH0779711 B2 JP H0779711B2 JP 13953493 A JP13953493 A JP 13953493A JP 13953493 A JP13953493 A JP 13953493A JP H0779711 B2 JPH0779711 B2 JP H0779711B2
- Authority
- JP
- Japan
- Prior art keywords
- carboxylic acid
- indoline
- optically active
- producing
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- QNRXNRGSOJZINA-UHFFFAOYSA-N indoline-2-carboxylic acid Chemical compound C1=CC=C2NC(C(=O)O)CC2=C1 QNRXNRGSOJZINA-UHFFFAOYSA-N 0.000 title claims description 25
- 230000003287 optical effect Effects 0.000 title claims description 9
- 238000004519 manufacturing process Methods 0.000 title claims description 7
- 108090000790 Enzymes Proteins 0.000 claims description 18
- 102000004190 Enzymes Human genes 0.000 claims description 18
- 244000005700 microbiome Species 0.000 claims description 18
- 238000000034 method Methods 0.000 claims description 11
- 150000001875 compounds Chemical class 0.000 claims description 10
- 150000002148 esters Chemical class 0.000 claims description 9
- 239000000126 substance Substances 0.000 claims description 9
- 241000589516 Pseudomonas Species 0.000 claims description 8
- QNRXNRGSOJZINA-QMMMGPOBSA-N (2s)-2,3-dihydro-1h-indole-2-carboxylic acid Chemical compound C1=CC=C2N[C@H](C(=O)O)CC2=C1 QNRXNRGSOJZINA-QMMMGPOBSA-N 0.000 claims description 7
- 241000228212 Aspergillus Species 0.000 claims description 6
- 108090000371 Esterases Proteins 0.000 claims description 6
- 230000000707 stereoselective effect Effects 0.000 claims description 5
- 125000001931 aliphatic group Chemical group 0.000 claims description 4
- 230000000694 effects Effects 0.000 claims description 4
- 239000013543 active substance Substances 0.000 claims description 3
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 claims 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 18
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 18
- 239000000243 solution Substances 0.000 description 18
- 238000006243 chemical reaction Methods 0.000 description 17
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- 238000006460 hydrolysis reaction Methods 0.000 description 15
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 12
- 238000000605 extraction Methods 0.000 description 9
- 239000000758 substrate Substances 0.000 description 9
- 230000007062 hydrolysis Effects 0.000 description 8
- 239000003960 organic solvent Substances 0.000 description 8
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 7
- 239000002609 medium Substances 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- 230000000813 microbial effect Effects 0.000 description 6
- 238000005119 centrifugation Methods 0.000 description 5
- 235000011121 sodium hydroxide Nutrition 0.000 description 5
- 238000001914 filtration Methods 0.000 description 4
- 239000008363 phosphate buffer Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 229940041514 candida albicans extract Drugs 0.000 description 3
- 150000001732 carboxylic acid derivatives Chemical group 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 230000003301 hydrolyzing effect Effects 0.000 description 3
- 230000002209 hydrophobic effect Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 239000012138 yeast extract Substances 0.000 description 3
- QNRXNRGSOJZINA-MRVPVSSYSA-N (2r)-2,3-dihydro-1h-indole-2-carboxylic acid Chemical compound C1=CC=C2N[C@@H](C(=O)O)CC2=C1 QNRXNRGSOJZINA-MRVPVSSYSA-N 0.000 description 2
- ASNHGEVAWNWCRQ-UHFFFAOYSA-N 4-(hydroxymethyl)oxolane-2,3,4-triol Chemical compound OCC1(O)COC(O)C1O ASNHGEVAWNWCRQ-UHFFFAOYSA-N 0.000 description 2
- 239000005696 Diammonium phosphate Substances 0.000 description 2
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 2
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 2
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 238000006482 condensation reaction Methods 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- MNNHAPBLZZVQHP-UHFFFAOYSA-N diammonium hydrogen phosphate Chemical compound [NH4+].[NH4+].OP([O-])([O-])=O MNNHAPBLZZVQHP-UHFFFAOYSA-N 0.000 description 2
- 229910000388 diammonium phosphate Inorganic materials 0.000 description 2
- 235000019838 diammonium phosphate Nutrition 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 2
- 235000019796 monopotassium phosphate Nutrition 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 108091016642 steapsin Proteins 0.000 description 2
- 241000228245 Aspergillus niger Species 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- 208000005156 Dehydration Diseases 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 108010013563 Lipoprotein Lipase Proteins 0.000 description 1
- 102100022119 Lipoprotein lipase Human genes 0.000 description 1
- 102000004270 Peptidyl-Dipeptidase A Human genes 0.000 description 1
- 108090000882 Peptidyl-Dipeptidase A Proteins 0.000 description 1
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 238000005904 alkaline hydrolysis reaction Methods 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 239000002220 antihypertensive agent Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000001733 carboxylic acid esters Chemical class 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000007515 enzymatic degradation Effects 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- KDCIHNCMPUBDKT-UHFFFAOYSA-N hexane;propan-2-one Chemical compound CC(C)=O.CCCCCC KDCIHNCMPUBDKT-UHFFFAOYSA-N 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 239000013028 medium composition Substances 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000011027 product recovery Methods 0.000 description 1
- 238000011403 purification operation Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000011218 seed culture Methods 0.000 description 1
- XHFLOLLMZOTPSM-UHFFFAOYSA-M sodium;hydrogen carbonate;hydrate Chemical class [OH-].[Na+].OC(O)=O XHFLOLLMZOTPSM-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000013076 target substance Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Description
【0001】[0001]
【産業上の利用分野】本発明は、一般式I This invention is of general formula I
【0002】[0002]
【化7】 [Chemical 7]
【0003】(式中、RはC2 〜C8 の脂肪族炭化水素
基)で表わされる(R,S)−インドリン−2−カルボ
ン酸エステルを不斉的に加水分解して、構造式(S)−
II (In the formula, R is a C 2 -C 8 aliphatic hydrocarbon group) and (R, S) -indoline-2-carboxylic acid ester is asymmetrically hydrolyzed to give a structural formula ( S)-
II
【0004】[0004]
【化8】 [Chemical 8]
【0005】で表わされる光学活性(S)−インドリン
−2−カルボン酸を生成させる立体選択的エステラーゼ
活性を有するシュードモナス(Pseudomonas)属に属する
微生物或いはシュードモナス(Pseudomonas)属もしくは
アスペルギルス(Aspergillus)属に属する微生物由来の
酵素を作用させることにより、ラセミ体Iを光学活性な
化合物インドリン−2−カルボン酸(S)−IIと一般式
(R)−I A microorganism belonging to the genus Pseudomonas having a stereoselective esterase activity for producing an optically active (S) -indoline-2-carboxylic acid represented by or belonging to the genus Pseudomonas or Aspergillus. by the action of enzymes derived from microorganisms, the racemic I optically active compounds indoline-2-carboxylic acid (S) - II and general formula (R) - I
【0006】[0006]
【化9】 [Chemical 9]
【0007】(Rは前記と同じ)で表わされる光学活性
インドリン−2−カルボン酸エステルとに光学分割し、
夫々の光学活性体を分を分離、採取し、更に必要に応
じ、採取した(R)−Iを加水分解して(S)−IIの対
掌体(R)−IIを生成させ、採取することを特徴とする
光学分割によるインドリン−2−カルボン酸エステルの
製造方法に関する。Optically resolved to an optically active indoline-2-carboxylic acid ester represented by the formula (R is the same as above),
Separating the partial optically active body each, were collected and further optionally, collected (R) - I hydrolyzed to (S) a - antipode II (R) - II to generate, taken And a method for producing an indoline-2-carboxylic acid ester by optical resolution.
【0008】本発明は、使用する立体選択的エステラー
ゼを選ぶことにより、(S)−インドリン−2−カルボ
ン酸エステル及び(R)−インドリン−2−カルボン酸
エステルを随意採取することができる。これら光学活性
インドリン−2−カルボン酸類化合物は種々医薬品の原
料となりうる。例えば、(S)−インドリン−2−カル
ボン酸はアンジオテンシンI変換酵素の阻害剤として有
効な血圧降下剤である(S)−1−〔(S)−3−メル
カプト−2−オキソプロピル〕−インドリン−2−カル
ボン酸In the present invention, (S) -indoline-2-carboxylic acid ester and (R) -indoline-2-carboxylic acid ester can be optionally collected by selecting the stereoselective esterase to be used. These optically active indoline-2-carboxylic acid compounds can be used as raw materials for various medicines. For example, (S) -indoline-2-carboxylic acid is a hypotensive agent effective as an inhibitor of angiotensin I converting enzyme, (S) -1-[(S) -3-mercapto-2-oxopropyl] -indoline. -2-carboxylic acid
【0009】[0009]
【化10】 [Chemical 10]
【0010】等に利用できる〔文献 J.Med. Chem., 2
6,394(1983)〕。[Reference J. Med. Chem.,2
6, 394 (1983)].
【0011】[0011]
【従来の技術】これら光学活性なインドリン−2−カル
ボン酸類の製造については、下記に示すような光学分割
剤を用いる方法が知られている。2. Description of the Related Art For the production of these optically active indoline-2-carboxylic acids, a method using an optical resolving agent as shown below is known.
【0012】[0012]
【化11】 [Chemical 11]
【0013】[0013]
【発明が解決しようとする課題】これら分割剤を用いた
光学分割法は操作が煩雑であり、大量生産に適した簡便
な方法により光学活性インドリン−2−カルボン酸又は
光学活性インドリン−2−カルボン酸エステルを得る方
法の開発が望まれていた。The optical resolution method using these resolving agents is complicated in operation, and is a simple method suitable for mass production, which is an optically active indoline-2-carboxylic acid or an optically active indoline-2-carboxylic acid. Development of the method of obtaining an acid ester was desired.
【0014】[0014]
【課題を解決するための手段】本発明者らは、インドリ
ン−2−カルボン酸のカルボン酸部位を種々アルコール
を用いてエステル化し、このエステル体に微生物菌体或
いは酵素を作用させて不斉加水分解を行えば光学活性体
を取得できると考え、検討を重ねてきた。その結果、シ
ュードモナス(Pseudomonas)属又はアスペルギルス(As
pergillus)属に属する微生物或いは該微生物から得られ
る酵素を作用させ、不斉的に加水分解し、(S)−イン
ドリン−2−カルボン酸(S)−IIと(R)−インドリ
ン−2−カルボン酸エステルR−Iを生成させた後、有
機溶媒で分離、抽出することにより(S)−IIと(R)
−Iを夫々採取でき、更に採取した(R)−Iをアルカ
リ加水分解、又は酵素分解を行って(R)−IIを生成、
採取できることを見い出し、本発明を完成した。以下
に、本発明を更に詳細に説明する。[Means for Solving the Problems] The inventors of the present invention esterify the carboxylic acid moiety of indoline-2-carboxylic acid with various alcohols, and act microbial cells or enzymes on the ester to asymmetrically hydrolyze the ester. We have conducted repeated studies, thinking that an optically active substance can be obtained by decomposition. As a result, Pseudomonas or Aspergillus (As
Pergillus) reacted with an enzyme derived from a microorganism or microorganism belonging to the genus asymmetrically hydrolyze, (S) - indoline-2-carboxylic acid (S) - II and (R) - indoline-2-carboxylic After the acid ester R- I is formed, (S) -II and (R) can be obtained by separating and extracting with an organic solvent.
- I can respectively collected and further collected (R) - alkaline hydrolysis of I, or by performing the enzymatic degradation (R) - generate II,
They have found that they can be collected and completed the present invention. Hereinafter, the present invention will be described in more detail.
【0015】本発明の基質として用いられる、一般式The general formula used as the substrate of the present invention
【0016】[0016]
【化12】 [Chemical 12]
【0017】で表わされるインドリン−2−カルボン酸
エステルは、RがC2 〜C8 の脂肪族炭化水素基の化合
物であり、好ましくはエチル、ブチル、アミル、ヘキシ
ル基からなるエステルである。The indoline-2-carboxylic acid ester represented by the formula (1) is a compound in which R is a C 2 -C 8 aliphatic hydrocarbon group, and is preferably an ester consisting of ethyl, butyl, amyl and hexyl groups.
【0018】インドリン−2−カルボン酸エステルIは
次のようにして得られる。即ち(R,S)−インドリン
−2−カルボン酸に溶媒と反応試剤とを兼ねたアルコー
ルを加え、インドリン−2−カルボン酸の濃度5〜20
%(w/v)の範囲で、強酸性下、50℃〜還流温度の
範囲で1〜5時間縮合反応を行う。更に、この反応液を
pH7.0に調整後、減圧濃縮により過剰のアルコール
を除去する。濃縮液に水又は飽和重炭酸ソーダを加え、
酢酸エチル又はヘキサン等のような疎水性有機溶媒を用
いて抽出し、更に濃縮すれば高純度の(R,S)−イン
ドリン−2−カルボン酸エステルIが得られる。The indoline-2-carboxylic acid ester I is obtained as follows. That is, an alcohol serving as a solvent and a reaction reagent is added to (R, S) -indoline-2-carboxylic acid to give a concentration of indoline-2-carboxylic acid of 5 to 20.
% (W / v), the condensation reaction is carried out under strong acidity in the range of 50 ° C. to reflux temperature for 1 to 5 hours. Further, this reaction solution is adjusted to pH 7.0 and then concentrated under reduced pressure to remove excess alcohol. Add water or saturated sodium bicarbonate to the concentrate,
Extraction using a hydrophobic organic solvent such as ethyl acetate or hexane, and further concentration give (R, S) -indoline-2-carboxylic acid ester I of high purity.
【0019】ラセミ体Iを不斉的に加水分解し、(S)
−IIを生成させる立体選択的エステラーゼを有する微生
物としては、例えばシュードモナス属或いはアスプルギ
ル属等に属する微生物があり、更に詳しくは、シュード
モナス・アエルギノサ(Pseudomonas aeruginosa) IFO
3080, IFO 13130 やアスペルギルス・ニガー(Aspergil
lus niger) IFO 4407 がある。これら微生物の培養は、
微生物が生育できる栄養培地であれば良く、例えばグル
コース、ペプトン、酵母エキス、肉エキス等から成る栄
養培地が用いられる。培地中の培養温度は10〜40
℃、好ましくは25〜35℃であり、pHは3〜8、好
ましくは6〜7であり、好気的に培養し、通常24〜4
8時間行えば良い。Asymmetric hydrolysis of the racemate I (S)
-As a microorganism having a stereoselective esterase that produces II , for example, there is a microorganism belonging to the genus Pseudomonas or the genus Aspurgill, more specifically, Pseudomonas aeruginosa (Pseudomonas aeruginosa) IFO
3080, IFO 13130 and Aspergil Niger
lus niger) There is an IFO 4407. Culture of these microorganisms
Any nutrient medium can be used as long as it can grow microorganisms. For example, a nutrient medium composed of glucose, peptone, yeast extract, meat extract and the like is used. Culture temperature in the medium is 10-40
C., preferably 25-35.degree. C., pH 3-8, preferably 6-7, aerobically cultivated, usually 24-4.
You only have to do it for 8 hours.
【0020】インドリン−2−カルボン酸エステルの微
生物による不斉加水分解反応においては、培養の開始と
同時に培地中と基質即ち該化合物Iを添加し、培養と並
行して加水分解を行う方法、培養により得られた菌体含
有培養液に化合物Iを添加する、あるいは培養後、遠心
分離または濾過を行って得た菌体を緩衝液に懸濁させた
菌体懸濁液中で、化合物Iと接触させて加水分解を行う
方法等があるが、望ましくは、菌体を遠心分離あるいは
濾過等で濃縮後、高濃度菌体懸濁液とし、このものに化
合物Iを添加する方法が反応後の生産物回収の立場から
秀れている。In the asymmetric hydrolysis reaction of indoline-2-carboxylic acid ester by a microorganism, at the same time as the start of the culture, the substrate and the compound I are added to the medium and the hydrolysis is carried out in parallel with the culture. Compound I is added to the microbial cell-containing culture solution obtained in step 1), or after culturing, the cells obtained by centrifugation or filtration are suspended in a buffer solution to give compound I Although there is a method of contacting and hydrolyzing the cells, it is desirable to concentrate the cells by centrifugation or filtration to obtain a high-concentration cell suspension, and to add the compound I to this suspension after the reaction. Excellent from the standpoint of product recovery.
【0021】化合物Iの水に対する溶解度は一般に低い
が、攪拌すれば本反応にとって支障とはならない。又、
例えばアセトン、メタノール等の有機溶媒や界面活性剤
等を反応に支障とならない程度加えても良い。The solubility of the compound I in water is generally low, but stirring does not hinder the reaction. or,
For example, an organic solvent such as acetone or methanol, a surfactant or the like may be added to such an extent that the reaction is not hindered.
【0022】反応条件は温度10〜40℃、好ましくは
25〜35℃の範囲であり、pHは5〜8、好ましくは
6.5〜7.5の範囲で行い、反応時間は基質及び菌体
量の比により変化するが、未反応のエステルと生成物の
カルボン酸がモル比50%に達したところで止めれば良
い。但し、菌体の反応活性の観点から通常24〜72時
間で50%に達するように基質の添加量を決めるのが望
ましい。The reaction conditions are a temperature of 10 to 40 ° C., preferably 25 to 35 ° C., a pH of 5 to 8, preferably 6.5 to 7.5, and a reaction time of substrate and bacterial cells. Although it varies depending on the ratio of the amounts, it may be stopped when the unreacted ester and the carboxylic acid as the product reach a molar ratio of 50%. However, from the viewpoint of the reaction activity of the bacterial cells, it is usually desirable to determine the addition amount of the substrate so as to reach 50% in 24 to 72 hours.
【0023】酵素を用いる方法としては、該微生物菌体
を破砕後、硫安分画やアセトン処理して得られる粗酵
素、或いは更にカラムクロマトグラフィー操作を行い、
得られる精製酵素が使用できる。市販されている酵素と
しては、例えばリポプロテインリパーゼ(L.P.L.
アマノ3,起源;シュードモナス・アエルギノサ、天野
製薬株式会社製)やリパーゼAP−6(起源;アスペル
ギルス・ニガー、天野製薬株式会社製)等を使用するこ
ともできる。As a method using an enzyme, after crushing the microbial cells, crude enzyme obtained by ammonium sulfate fractionation or acetone treatment, or further column chromatography operation is carried out,
The resulting purified enzyme can be used. Examples of commercially available enzymes include lipoprotein lipase (L.P.L.
Amano 3, origin: Pseudomonas aeruginosa, manufactured by Amano Pharmaceutical Co., Ltd., lipase AP-6 (origin: Aspergillus niger, manufactured by Amano Pharmaceutical Co., Ltd.) and the like can also be used.
【0024】不斉加水分解反応は、基質のラセミ体Iを
濃度2〜80%(w/v)の範囲で反応液に懸濁し、酵
素を適量、例えば酵素と基質の重量比として1:5ない
し1:1000の割合で加え、温度10〜40℃、好ま
しく25〜35℃の範囲で反応を行い、高速液体クロマ
トグラフィーによってカルボン酸の生成量及びカルボン
酸エステルの減少量を測定し、反応液中の(R)−Iと
(S)−IIのモル比50%になった時点で反応を止めれ
ば良い。また加水分解を行う際のpH範囲は4〜8.5
であれば良いが、加水分解反応が進むに従い、反応液中
のpHが酸性側に傾くので、中和剤例えばNaOH溶液等で
pHを6〜7に保持するのが望ましい。更に、上記の不
斉加水分解反応を、例えば微生物菌体或いは酵素を固定
化させることにより繰り返し行うこともできる。In the asymmetric hydrolysis reaction, the racemate I of the substrate is suspended in the reaction solution at a concentration of 2 to 80% (w / v), and the enzyme is added in an appropriate amount, for example, the weight ratio of the enzyme to the substrate is 1: 5. To 1: 1000, and the reaction is carried out at a temperature of 10 to 40 ° C., preferably 25 to 35 ° C., and the production amount of carboxylic acid and the reduction amount of carboxylic acid ester are measured by high performance liquid chromatography. in (R) - I and (S) - they become 50 mol% of II may be stopped the reaction. The pH range for hydrolysis is 4-8.5.
However, since the pH of the reaction solution tends to be acidic as the hydrolysis reaction proceeds, it is desirable to maintain the pH at 6 to 7 with a neutralizing agent such as NaOH solution. Furthermore, the above-mentioned asymmetric hydrolysis reaction can be repeated by immobilizing microbial cells or enzymes, for example.
【0025】微生物或いは酵素を用いて不斉加水分解し
た後、反応液中の(S)−IIと(R)−Iを分離する方
法としては、疎水性の有機溶剤例えばヘキサン、シクロ
ヘキサン、トルエン等で疎水性の光学活性インドリン−
2−カルボン酸エステル(R)−Iのみを抽出し、親水
性の光学活性インドリン−2−カルボン酸(S)−IIと
容易に分離することができる。As a method for separating (S) -II and (R) -I in the reaction solution after asymmetric hydrolysis using a microorganism or enzyme, a hydrophobic organic solvent such as hexane, cyclohexane or toluene is used. And hydrophobic optically active indoline-
2-carboxylic acid ester (R) - extracting I only, hydrophilic optically active indoline-2-carboxylic acid (S) - can be readily separated and II.
【0026】分離して得られた光学活性インドリン−2
−カルボン酸エステルは、そのまま濃縮すれば高光学純
度のエステル体で得られるが、更に次のようにして光学
活性インドリン−2−カルボン酸とすることができる。
即ち、光学活性インドリン−2−カルボン酸エステル
(R)−Iを室温下、pH10〜13.5の範囲で2〜
5時間アルカリ加水分解を行えば、(R)−IIが生成す
る。また、(R)−Iを加水分解する能力を有する酵
素、例えばステアプシンを作用させて前記酵素による加
水分解条件下に加水分解を行えば、(R)−IIを得るこ
とができる。Optically active indoline-2 obtained by separation
The -carboxylic acid ester can be obtained as an ester with high optical purity by concentrating as it is, and can be further converted into an optically active indoline-2-carboxylic acid as follows.
That is, the optically active indoline-2-carboxylic acid ester (R) -I is added at room temperature at a pH of 10 to 13.5 in the range of 2 to
If alkali hydrolysis is carried out for 5 hours, (R) -II is produced. Furthermore, (R) - an enzyme having the ability to hydrolyze the I, for example, by performing hydrolysis in hydrolytic conditions by the enzyme by the action of steapsin, (R) - can be obtained II.
【0027】このようにして得られた加水分解液はpH
を4〜6、好ましくは5.0付近に調整後、塩化メチレ
ン、酢酸エチル等の有機溶媒で抽出し、濃縮後、アセト
ン等の有機溶媒中で晶析することにより高光学純度の
(R)−IIが得られる。一方、抽出分離の際、水層側に
残っている光学活性インドリン−2−カルボン酸も上記
した如く、pH4〜6、好ましくは5.0付近に調整
後、同様の抽出精製操作を行うことにより高光学純度の
(S)−IIを容易に得ることができる。The hydrolyzed liquid thus obtained has a pH of
Is adjusted to about 4 to 6, preferably about 5.0, extracted with an organic solvent such as methylene chloride and ethyl acetate, concentrated and then crystallized in an organic solvent such as acetone to obtain a high optical purity (R). -II is obtained. On the other hand, during extraction and separation, the optically active indoline-2-carboxylic acid remaining on the aqueous layer side is adjusted to pH 4 to 6, preferably around 5.0, as described above, and then subjected to the same extraction and purification operation. of enantiopure (S) - II can be easily obtained.
【0028】なお微生物菌体を用いる不斉加水分解反応
では、有機溶媒で抽出分離した後、水層側に菌体が残る
が、引き続きpHを下げて有機溶媒抽出操作を行えば、
目的物光学活性インドリン−2−カルボン酸を採取する
のに支障とはならない。また微生物菌体を遠心もしくは
濾過によって除去した後、前記の方法に基づいて、イン
ドリン−2−カルボン酸とインドリン−2−カルボン酸
エステルとを分離、抽出することができる。In the asymmetric hydrolysis reaction using microbial cells, the cells remain on the water layer side after extraction and separation with an organic solvent, but if the pH is subsequently lowered and the organic solvent extraction operation is performed,
It does not hinder the collection of the target optically active indoline-2-carboxylic acid. After removing the microbial cells by centrifugation or filtration, the indoline-2-carboxylic acid and the indoline-2-carboxylic acid ester can be separated and extracted based on the above method.
【0029】[0029]
【実施例】以下、実施例により本発明を具体的に説明す
るが、本発明はこれらの実施例に限定されるものではな
い。 参考例1 (R,S)−インドリン−2−カルボン酸アミルの製造 (R,S)−インドリン−2−カルボン酸(R,S)−
II50gをアミルアルコール500mlに溶解し、更に濃
塩酸100mlを添加し、95〜100℃の範囲で3時
間、縮合反応を行った。反応後、一旦冷却してから10
%苛性ソーダ液でpHを7.0に調整した。更に過剰量
のアミルアルコール及び水を減圧濃縮操作により除去し
た。濃縮液中には、目的物の(R,S)−インドリン−
2−カルボン酸アミル−(R,S)−Ia及び無機塩が
含まれている。この濃縮液に酢酸エチル1リットルを加
え、飽和重炭酸ソーダ水200mlで2回(計400ml)
洗浄後、酢酸エチル層を濃縮したところ(R,S)−I
aが60.8g、85%の収率で得られた。EXAMPLES The present invention will now be described in detail with reference to examples, but the present invention is not limited to these examples. Reference Example 1 Production of (R, S) -indoline-2-carboxylic acid amyl (R, S) -Indoline-2-carboxylic acid (R, S)-
50 g of II was dissolved in 500 ml of amyl alcohol, 100 ml of concentrated hydrochloric acid was further added, and a condensation reaction was carried out at 95 to 100 ° C. for 3 hours. After the reaction, cool once and
The pH was adjusted to 7.0 with% caustic soda solution. Further, excess amyl alcohol and water were removed by vacuum concentration operation. In the concentrated liquid, the target substance (R, S) -indoline-
2-carboxylic acid amyl - (R, S) - Ia and inorganic salts are included. To this concentrated solution was added 1 liter of ethyl acetate, and twice with 200 ml of saturated sodium bicarbonate water (total 400 ml).
After washing, the ethyl acetate layer was concentrated (R, S) -I
60.8 g of a was obtained in a yield of 85%.
【0030】参考例2 100mlの0.1Mリン酸緩衝液(pH7.0)に、ス
テアプシンを1.0g及び基質(R,S)−インドリン
−2−カルボン酸アミルIa Reference Example 2 In 100 ml of 0.1 M phosphate buffer (pH 7.0), 1.0 g of steapsin and a substrate (R, S) -indoline-2-carboxylate amyl Ia were added.
【0031】[0031]
【化13】 [Chemical 13]
【0032】10gを添加し、1N NaOH溶液でpHを
7.0に調整しながら、攪拌下、30℃で24時間不斉
加水分解反応を行った。この反応液を100mlのヘキサ
ンで2回抽出操作を行い、ヘキサン層を無水硫酸ソーダ
で脱水後、減圧濃縮したところ、比旋光度〔α〕25 D +
5.8°(c=1.0、エタノール)を有するシロップ
(S)−Iaが4.7g((R,S)−Iaからの収率
94%)得られた。 1HNMR(90MHz)測定値は次の
通りであった。1 H NMR(CDCl3 )δppm:0.8〜 1.
8(9H, m, CH3CH2CH2CH2−),3.2〜3.45(2H,
d, −CH 2O−),4.0〜4.4(4H), 6.45〜7.
05(4H, m, Ar−) 得られた(S)−Iaの4.7gを25mlの1NNaOH溶
液に添加し、室温下、約3時間加水分解を行い、反応液
を1N塩酸でpH5.0に調整後、酢酸エチル50mlで
4回抽出操作を行った。更に無水硫酸ソーダで脱水処理
後、減圧濃縮し、乾固物をアセトン−ヘキサン(5ml−
1ml)で再結すると比旋光度〔α〕25 D+32.4°
(c=1.0、ジメチルホルムアミド)(文献値、J. M
ed. Chem.,26, 394 (1983), 〔α〕25 D +34.5°
(c=1.0、ジメチルホルムアミド)を有する白色の
粉末(S)−インドリン−2−カルボン酸(S)−IIが
2.45g((R,S)−Iaよりの収率69%)得ら
れた。1H NMR(90MHz)測定値は次の通りであっ
た。1 H NMR(DMSO−d6) δppm:2.85 〜3.
45(2H),4.10〜4.35(1H),6.40
〜7.05(4H, m, Aryl),7.2〜9.0(2H, b
road) 。 一方、ヘキサン抽出後の水層を1N塩酸でpH5.0に
調整し、酢酸エチルを100mlづつ用いて4回抽出を繰
返し、以下(S)−IIの場合と同様の操作を行い、
(R)−IIが2.6g((R,S)−Iaからの収率7
4%)得られた。比旋光度〔α〕25 D −33.1°(c
=1.0、ジメチルホルムアミド)であった。10 g was added and the asymmetric hydrolysis reaction was carried out at 30 ° C. for 24 hours while stirring while adjusting the pH to 7.0 with a 1N NaOH solution. The reaction solution was extracted twice with 100 ml of hexane, and the hexane layer was dehydrated with anhydrous sodium sulfate and concentrated under reduced pressure. The specific optical rotation [α] 25 D +
5.8 ° (c = 1.0, ethanol) Syrup (S) with - Ia is 4.7 g - obtained ((R, S) 94% yield from Ia). 1 HNMR (90 MHz) measured values were as follows. 1 H NMR (CDCl 3 ) δppm: 0.8 to 1.
8 (9H, m, CH 3 CH 2 CH 2 CH 2 −), 3.2 to 3.45 (2H,
d, - CH 2 O -) , 4.0~4.4 (4H), 6.45~7.
05 (4H, m, Ar-) resulting (S) - the 4.7g of Ia added to 1NNaOH solution of 25 ml, at room temperature, carried out for approximately 3 hours hydrolysis, the reaction solution with 1N hydrochloric acid pH5.0 After adjusting to 2, the extraction operation was performed 4 times with 50 ml of ethyl acetate. Further, after dehydration treatment with anhydrous sodium sulfate, the mixture was concentrated under reduced pressure, and the dried solid matter was mixed with acetone-hexane (5 ml-
(1ml) reconstituted for specific rotation [α] 25 D + 32.4 °
(C = 1.0, dimethylformamide) (literature value, J. M.
ed. Chem., 26 , 394 (1983), [α] 25 D + 34.5 °
(C = 1.0, dimethylformamide) white powder with (S) - indoline-2-carboxylic acid (S) - II is 2.45g ((R, S) - 69% yield from Ia) to give Was given. 1 H NMR (90 MHz) measured values were as follows. 1 H NMR (DMSO-d6) δ ppm: 2.85-3.
45 (2H), 4.10 to 4.35 (1H), 6.40
~ 7.05 (4H, m, Aryl), 7.2 to 9.0 (2H, b
road). On the other hand, the aqueous layer was adjusted after hexane extraction to pH5.0 with 1N hydrochloric acid, ethyl acetate with 100ml increments repeated 4 times extraction, following (S) - The same procedure as in II,
(R) - II is 2.6g ((R, S) - yield from Ia 7
4%) was obtained. Specific rotation [α] 25 D −33.1 ° (c
= 1.0, dimethylformamide).
【0033】実施例1〜2 酵素をかえて、参考例2と同様の操作を行い、表1の結
果を得た。Examples 1 to 2 The same operation as in Reference Example 2 was carried out by changing the enzyme, and the results shown in Table 1 were obtained.
【0034】[0034]
【表1】 [Table 1]
【0035】実施例3 下記の組成からなる栄養液体培地を調製し、2リットル
坂口フラスコに400mlずつ分注後、120℃、15分
殺菌した。 〔培地組成〕グルコース4%、イーストエキス0.3
%、肉エキス0.3%、ペプトン0.3%、リン酸二ア
ンモニウム0.2%、リン酸一カリウム0.1%(pH
6.8)Example 3 A nutrient liquid medium having the following composition was prepared, dispensed into a 2-liter Sakaguchi flask by 400 ml, and sterilized at 120 ° C. for 15 minutes. [Media composition] Glucose 4%, yeast extract 0.3
%, Meat extract 0.3%, peptone 0.3%, diammonium phosphate 0.2%, monopotassium phosphate 0.1% (pH
6.8)
【0036】これとは別に同じ組成の培地にて前培養を
したシュードモナス・アエルギノサIFO 3080 の種菌液
10mlを前記培養培地に接種し、30℃、24時間振と
うを行った。合計5本培養し、培養液計2リットルを得
た。この培養液を遠心分離し、菌体を集めた。この菌体
を0.1Mリン酸緩衝液(pH7.0)200mlに懸濁
し、基質(R,S)−インドリン−2−カルボン酸アミ
ルIaを2.0g添加した。これを500ml容器内で攪
拌下、1N NaOH溶液でpHを7.0に調整しながら、
30℃、18時間反応させた。反応後、遠心分離して得
た上清を各200mlのヘキサンで4回抽出分離を行い、
次いで参考例2に準じて同様の操作を行い、表2に示す
結果を得た。Separately, 10 ml of a seed culture of Pseudomonas aeruginosa IFO 3080 pre-cultured in a medium having the same composition was inoculated into the culture medium and shaken at 30 ° C. for 24 hours. A total of 5 cultures were performed to obtain a total of 2 liters of culture solution. The culture was centrifuged to collect bacterial cells. The cells were suspended in 200 ml of 0.1 M phosphate buffer (pH 7.0), and 2.0 g of substrate (R, S) -indoline-2-carboxylate amyl Ia was added. While stirring this in a 500 ml container while adjusting the pH to 7.0 with a 1N NaOH solution,
The reaction was carried out at 30 ° C for 18 hours. After the reaction, the supernatant obtained by centrifugation is extracted and separated four times with 200 ml of hexane each time,
Then, the same operation as in Reference Example 2 was performed, and the results shown in Table 2 were obtained.
【0037】実施例4〜5 実施例4のシュードモナス・アエルギノサ IFO 13130
の培養は実施例4と同様に培養し、実施例5のアスペル
ギルス属の微生物の培養はグルコース8.0%、ポリペ
プトン1.0%、イーストエキス0.5%、リン酸二ア
ンモニウム0.2%、リン酸一カリウム0.1%(pH
6.5)の培地を用い、温度を28℃とした他は実施例
3と同様に行った。各菌株は、培養後、シュードモナス
・アエルギノサは遠心分離にて、アスペルギルス層の微
生物は濾過で、それぞれ菌体を集め、0.1Mリン酸緩
衝液pH7.0に懸濁し、以下実施例4に準じて微生物
による不斉加水分解反応及び抽出、精製を行い、表2に
示す結果を得た。Examples 4-5 Pseudomonas aeruginosa IFO 13130 of Example 4
Was cultured in the same manner as in Example 4, and the culture of the microorganism of the genus Aspergillus of Example 5 was 8.0% glucose, 1.0% polypeptone, 0.5% yeast extract, 0.2% diammonium phosphate. , Monopotassium phosphate 0.1% (pH
The same procedure as in Example 3 was performed except that the medium of 6.5) was used and the temperature was 28 ° C. After culturing, each strain was subjected to centrifugation for Pseudomonas aeruginosa and filtration for microorganisms in the Aspergillus layer, and the cells were collected and suspended in 0.1 M phosphate buffer pH 7.0. Asymmetric hydrolysis reaction by a microorganism, extraction and purification were carried out, and the results shown in Table 2 were obtained.
【0038】[0038]
【表2】 [Table 2]
【0039】実施例6 シュードモナス・アエルギノサ IFO 3080 を用いて前記
実施例4と同様にして得た培養液2リットルを遠心分離
し、菌体を集めた。この菌体を0.1Mリン酸緩衝液
(pH7.0)200mlに懸濁し、氷冷しながらブラウ
ンホモジナイザーで菌体破砕し、遠心分離して無細胞抽
出酵素液を得た。この酵素液に基質(R,S)−インド
リン−2−カルボン酸アミルIaを10g添加し、1N
NaOH溶液でpHを7.0に調整しながら攪拌下、30
℃、48時間不斉加水分解を行った。以下、実施例3に
準じて抽出精製を行い、比旋光度〔α〕25 D +22.4
°(c=1.0、ジメチルホルムアミド)を有する
(S)−IIが1.9gと比旋光度〔α〕25 D −3.3°
(c=1.0、エタノール)を有する(R)−Ia4.
2gを得た。Example 6 Using a Pseudomonas aeruginosa IFO 3080, 2 liters of the culture solution obtained in the same manner as in Example 4 was centrifuged to collect the cells. The cells were suspended in 200 ml of 0.1M phosphate buffer (pH 7.0), disrupted with a Brown homogenizer while cooling with ice, and centrifuged to obtain a cell-free extract enzyme solution. To this enzyme solution, 10 g of substrate (R, S) -indoline-2-carboxylate amyl Ia was added, and 1N
While adjusting the pH to 7.0 with NaOH solution, under stirring,
Asymmetric hydrolysis was performed at 48 ° C. for 48 hours. Then, extraction and purification are carried out according to Example 3 to obtain a specific optical rotation [α] 25 D +22.4.
° (c = 1.0, dimethylformamide) with a (S) - II is 1.9g and a specific rotation of [α] 25 D -3.3 °
(R) -Ia with (c = 1.0, ethanol) 4.
2 g was obtained.
【0040】[0040]
【発明の効果】本発明によれば、立体選択性をもつ加水
分解酵素エステラーゼ又は、同加水分解能を有する微生
物を適宜選んで使用することにより、(R,S)−イン
ドリン−2−カルボン酸エステルから該エステルの光学
活性体の(R)体を、あるいは光学活性なインドリン−
2−カルボン酸の(R)体もしくは(S)体を得ること
が出来る。INDUSTRIAL APPLICABILITY According to the present invention, (R, S) -indoline-2-carboxylic acid ester can be obtained by appropriately selecting and using a hydrolase esterase having stereoselectivity or a microorganism having the same hydrolyzing ability. To an optically active (R) form of the ester, or an optically active indoline-
The (R) form or (S) form of 2-carboxylic acid can be obtained.
フロントページの続き (72)発明者 大橋 武久 兵庫県神戸市灘区篠原伯母野山町3−9− 14 (72)発明者 渡辺 清 兵庫県明石市松ケ丘5丁目15の41 (72)発明者 高原 謙治 兵庫県加古川市上荘町都台1−13−2Front Page Continuation (72) Inventor Takehisa Ohashi 3-9-14 Shinohara Auntanoyama-cho, Nada-ku, Kobe-shi, Hyogo (72) Inventor Kiyoshi Watanabe 5-41 Matsugaoka, Akashi-shi, Hyogo (72) Inventor Kenji Takahara 1-13-2 Miyakodai, Kamiso-cho, Kakogawa-shi, Hyogo
Claims (2)
れる(R,S)−インドリン−2−カルボン酸エステル
を不斉的に加水分解して、構造式(S)−II 【化2】 で表わされる光学活性(S)−インドリン−2−カルボ
ン酸を生成させる立体選択的エステラーゼ活性を有する
シュードモナス(Pseudomonas)属に属する微生物或いは
シュードモナス(Pseudomonas)属もしくはアスペルギル
ス(Aspergillus)属に属する微生物由来の酵素を作用さ
せることにより、ラセミ体Iを光学活性な化合物インド
リン−2−カルボン酸(S)−IIと一般式(R)−I 【化3】 (Rは前記と同じ)で表わされる光学活性インドリン−
2−カルボン酸エステルとに光学分割し、夫々の光学活
性体を分離採取することを特徴とする光学分割によるイ
ンドリン−2−カルボン酸の製造方法。1. The general formula I : (In the formula, R is a C 2 -C 8 aliphatic hydrocarbon group) and (R, S) -indoline-2-carboxylic acid ester is asymmetrically hydrolyzed to give a structural formula (S)- II [Chemical 2] Derived from a microorganism belonging to the genus Pseudomonas or a microorganism belonging to the genus Pseudomonas or Aspergillus having stereoselective esterase activity for producing optically active (S) -indoline-2-carboxylic acid By reacting an enzyme, the racemate I is converted to the optically active compound indoline-2-carboxylic acid (S) -II and the general formula (R) -I. (R is the same as above)
A method for producing indoline-2-carboxylic acid by optical resolution, which comprises optically resolving with a 2-carboxylic acid ester and separating and collecting each optically active substance.
れる(R,S)−インドリン−2−カルボン酸エステル
を不斉的に加水分解して、構造式(S)−II 【化5】 で表わされる光学活性(S)−インドリン−2−カルボ
ン酸を生成させる立体選択的エステラーゼ活性を有する
シュードモナス(Pseudomonas)属に属する微生物或いは
シュードモナス(Pseudomonas)属もしくはアスペルギル
ス(Aspergillus)属に属する微生物由来の酵素を作用さ
せることにより、ラセミ体Iを光学活性な化合物インド
リン−2−カルボン酸(S)−IIと一般式(R)−I 【化6】 (Rは前記と同じ)で表わされる光学活性インドリン−
2−カルボン酸エステルとに光学分割し、夫々の光学活
性体を分離、採取し、さらに(R)−Iを加水分解して
化合物(S)−IIの対掌体である光学活性インドリン−
2−カルボン酸(R)−IIを生成させ、採取することを
特徴とする光学活性インドリン−2−カルボン酸の製造
方法。2. The general formula I : (In the formula, R is a C 2 -C 8 aliphatic hydrocarbon group) and (R, S) -indoline-2-carboxylic acid ester is asymmetrically hydrolyzed to give a structural formula (S)- II [Chemical 5] Derived from a microorganism belonging to the genus Pseudomonas or a microorganism belonging to the genus Pseudomonas or Aspergillus having stereoselective esterase activity for producing optically active (S) -indoline-2-carboxylic acid By reacting an enzyme, the racemate I is converted into the optically active compound indoline-2-carboxylic acid (S) -II and the general formula (R) -I (R is the same as above)
2-carboxylic acid is optically divided into the ester, separating the optically active substance of each were taken, further (R) - I and hydrolyzed to the compound (S) - optically active indoline a antipode II -
2- carboxylic acid (R) - II to produce a process for producing an optically active indoline-2-carboxylic acid, and recovering.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP13953493A JPH0779711B2 (en) | 1993-05-17 | 1993-05-17 | Method for producing indoline-2-carboxylic acid by optical resolution |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP13953493A JPH0779711B2 (en) | 1993-05-17 | 1993-05-17 | Method for producing indoline-2-carboxylic acid by optical resolution |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP21198684A Division JPS6192595A (en) | 1984-10-09 | 1984-10-09 | Production of indoline-2-carboxylic acid by optical resolution |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH0662892A JPH0662892A (en) | 1994-03-08 |
| JPH0779711B2 true JPH0779711B2 (en) | 1995-08-30 |
Family
ID=15247519
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP13953493A Expired - Fee Related JPH0779711B2 (en) | 1993-05-17 | 1993-05-17 | Method for producing indoline-2-carboxylic acid by optical resolution |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH0779711B2 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100463903C (en) * | 2003-11-26 | 2009-02-25 | Sk股份有限公司 | Method for preparing (S)-indoline-2-carboxylic acid and (S)-indoline-2-carboxylic acid methyl ester using hydrolase |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100330359B1 (en) * | 1999-11-01 | 2002-04-01 | 복성해 | Novel esterase derived from Pseudomonas aeruginosa, its gene and process for production of optically active carboxylic acids using them |
| CN116655519A (en) * | 2023-06-13 | 2023-08-29 | 上海吉奉生物科技有限公司 | Asymmetric chiral conversion method of S- (-) -indoline-2-carboxylic acid |
-
1993
- 1993-05-17 JP JP13953493A patent/JPH0779711B2/en not_active Expired - Fee Related
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100463903C (en) * | 2003-11-26 | 2009-02-25 | Sk股份有限公司 | Method for preparing (S)-indoline-2-carboxylic acid and (S)-indoline-2-carboxylic acid methyl ester using hydrolase |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0662892A (en) | 1994-03-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0197474B1 (en) | Process for preparing optically active indoline-2-carboxylic acid | |
| JP2009022270A (en) | Bioresolution of n-acylazetidine-2-carboxylic acid | |
| CA2116003C (en) | Arylalkanoic acid resolution | |
| JPS5931693A (en) | Preparation of optical active oxazolidinone derivative | |
| JPH0779711B2 (en) | Method for producing indoline-2-carboxylic acid by optical resolution | |
| EP0101076B1 (en) | Process for production of optically active oxazolidinone derivative | |
| JPH0578310B2 (en) | ||
| JPH0573396B2 (en) | ||
| JP3732535B2 (en) | Process for producing optically active α-methylalkanedicarboxylic acid-ω-monoester and its enantiomer diester | |
| JPS63245694A (en) | Production of optically active sulfur-containing carboxylic acid and antipodal ester thereof | |
| JP3970898B2 (en) | Process for producing optically active α-methylalkanedicarboxylic acid-ω-monoester and its enantiomer diester | |
| JP2639651B2 (en) | Process for producing optically active carboxylic acid and its enantiomer ester | |
| JPH0533995B2 (en) | ||
| JP3715662B2 (en) | Process for producing optically active β-hydroxycarboxylic acid and its enantiomer ester | |
| JP3218772B2 (en) | Method for producing acetylene alcohols | |
| JPS61265099A (en) | Production of optically active indolin-2-carboxylic acid | |
| JPH0965891A (en) | Method for producing optically active α-methylalkanoic acid derivative | |
| JPS6363396A (en) | Method for producing d-2-(6-methoxy-2-naphthyl)propionic acid | |
| JPH0353918B2 (en) | ||
| JP3545442B2 (en) | Method for producing optically active 4- (2-halo-1-hydroxyethyl) -2-trifluoromethylthiazole | |
| JPH01225499A (en) | Production of optically active 2-hydroxy-4-phenylbutyric acid ester | |
| JPH0253497A (en) | Production of optically active mandelic acid | |
| JPH0959217A (en) | Novel optically active halogen-containing carboxylic acid derivative and method for producing the same | |
| JPH0959211A (en) | Novel optically active dicarboxylic acid derivative and method for producing the same | |
| JPH10287620A (en) | Optically active methyl succinate and method for producing the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 19960227 |
|
| LAPS | Cancellation because of no payment of annual fees |